ENTRY       mmu04664                    Pathway
NAME        Fc epsilon RI signaling pathway - Mus musculus (mouse)
DESCRIPTION Fc epsilon RI-mediated signaling pathways in mast cells are initiated by the interaction of antigen (Ag) with IgE bound to the extracellular domain of the alpha chain of Fc epsilon RI. The activation pathways are regulated both positively and negatively by the interactions of numerous signaling molecules. Mast cells that are thus activated release preformed granules which contain biogenic amines (especially histamines) and proteoglycans (especially heparin). The activation of phospholipase A2 causes the release of membrane lipids followed by development of lipid mediators such as leukotrienes (LTC4, LTD4 and LTE4) and prostaglandins (especially PDG2). There is also secretion of cytokines, the most important of which are TNF-alpha, IL-4 and IL-5. These mediators and cytokines contribute to inflammatory responses.
CLASS       Organismal Systems; Immune system
PATHWAY_MAP mmu04664  Fc epsilon RI signaling pathway
DBLINKS     GO: 0045576
ORGANISM    Mus musculus (mouse) [GN:mmu]
GENE        14125  Fcer1a; Fc receptor, IgE, high affinity I, alpha polypeptide [KO:K08089]
            14126  Ms4a2; membrane-spanning 4-domains, subfamily A, member 2 [KO:K08090]
            14127  Fcer1g; Fc receptor, IgE, high affinity I, gamma polypeptide [KO:K07983]
            20963  Syk; spleen tyrosine kinase [KO:K05855] [EC:2.7.10.2]
            17096  Lyn; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]
            12229  Btk; Bruton agammaglobulinemia tyrosine kinase [KO:K07370] [EC:2.7.10.2]
            16331  Inpp5d; inositol polyphosphate-5-phosphatase D [KO:K03084] [EC:3.1.3.86]
            18803  Plcg1; phospholipase C, gamma 1 [KO:K01116] [EC:3.1.4.11]
            234779  Plcg2; phospholipase C, gamma 2 [KO:K05859] [EC:3.1.4.11]
            18750  Prkca; protein kinase C, alpha [KO:K02677] [EC:2.7.11.13]
            18706  Pik3ca; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            18707  Pik3cd; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            74769  Pik3cb; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            18709  Pik3r2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            18708  Pik3r1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            18710  Pik3r3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            18607  Pdpk1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
            11651  Akt1; thymoma viral proto-oncogene 1 [KO:K04456] [EC:2.7.11.1]
            11652  Akt2; thymoma viral proto-oncogene 2 [KO:K04456] [EC:2.7.11.1]
            23797  Akt3; thymoma viral proto-oncogene 3 [KO:K04456] [EC:2.7.11.1]
            19353  Rac1; Rac family small GTPase 1 [KO:K04392]
            19354  Rac2; Rac family small GTPase 2 [KO:K07860]
            170758  Rac3; Rac family small GTPase 3 [KO:K07861]
            26398  Map2k4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]
            26400  Map2k7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]
            26397  Map2k3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]
            26399  Map2k6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]
            26419  Mapk8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            26420  Mapk9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            26414  Mapk10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            26416  Mapk14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
            19094  Mapk11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
            29857  Mapk12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
            26415  Mapk13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
            16189  Il4; interleukin 4 [KO:K05430]
            16163  Il13; interleukin 13 [KO:K05435]
            16187  Il3; interleukin 3 [KO:K04736]
            16191  Il5; interleukin 5 [KO:K05428]
            12981  Csf2; colony stimulating factor 2 (granulocyte-macrophage) [KO:K05427]
            21926  Tnf; tumor necrosis factor [KO:K03156]
            16822  Lcp2; lymphocyte cytosolic protein 2 [KO:K07361]
            22324  Vav1; vav 1 oncogene [KO:K05730]
            22325  Vav2; vav 2 oncogene [KO:K05730]
            57257  Vav3; vav 3 oncogene [KO:K05730]
            14360  Fyn; Fyn proto-oncogene [KO:K05703] [EC:2.7.10.2]
            14389  Gab2; growth factor receptor bound protein 2-associated protein 2 [KO:K08091]
            16797  Lat; linker for activation of T cells [KO:K07362]
            14784  Grb2; growth factor receptor bound protein 2 [KO:K04364]
            20662  Sos1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
            20663  Sos2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
            15461  Hras; Harvey rat sarcoma virus oncogene [KO:K02833]
            16653  Kras; Kirsten rat sarcoma viral oncogene homolog [KO:K07827]
            18176  Nras; neuroblastoma ras oncogene [KO:K07828]
            110157  Raf1; v-raf-leukemia viral oncogene 1 [KO:K04366] [EC:2.7.11.1]
            26395  Map2k1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            26396  Map2k2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            26413  Mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            26417  Mapk3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            329502  Pla2g4e; phospholipase A2, group IVE [KO:K16342] [EC:3.1.1.4]
            18783  Pla2g4a; phospholipase A2, group IVA (cytosolic, calcium-dependent) [KO:K16342] [EC:3.1.1.4]
            211429  Pla2g4b; phospholipase A2, group IVB (cytosolic) [KO:K16342] [EC:3.1.1.4]
            232889  Pla2g4c; phospholipase A2, group IVC (cytosolic, calcium-independent) [KO:K16342] [EC:3.1.1.4]
            78390  Pla2g4d; phospholipase A2, group IVD [KO:K16342] [EC:3.1.1.4]
            271844  Pla2g4f; phospholipase A2, group IVF [KO:K16342] [EC:3.1.1.4]
            11689  Alox5; arachidonate 5-lipoxygenase [KO:K00461] [EC:1.13.11.34]
            11690  Alox5ap; arachidonate 5-lipoxygenase activating protein [KO:K20735]
COMPOUND    C00076  Calcium cation
            C00165  Diacylglycerol
            C00219  Arachidonate
            C00374  Heparin
            C00388  Histamine
            C00696  Prostaglandin D2
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C02166  Leukotriene C4
            C05951  Leukotriene D4
            C05952  Leukotriene E4
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
REFERENCE   PMID:12360215
  AUTHORS   Kawakami T, Galli SJ.
  TITLE     Regulation of mast-cell and basophil function and survival by IgE.
  JOURNAL   Nat Rev Immunol 2:773-86 (2002)
            DOI:10.1038/nri914
REFERENCE   PMID:14630197
  AUTHORS   Siraganian RP.
  TITLE     Mast cell signal transduction from the high-affinity IgE receptor.
  JOURNAL   Curr Opin Immunol 15:639-46 (2003)
            DOI:10.1016/j.coi.2003.09.010
REFERENCE   
  AUTHORS   Janeway CA, Travers P, Walport M, Shlomchik MJ.
  TITLE     Immunobiology 6th edition
  JOURNAL   Garland Science Publishing (2005)
REFERENCE   PMID:10586892
  AUTHORS   Turner H, Kinet JP.
  TITLE     Signalling through the high-affinity IgE receptor Fc epsilonRI.
  JOURNAL   Nature 402:B24-30 (1999)
            DOI:10.1038/35037021
REFERENCE   PMID:16470226
  AUTHORS   Gilfillan AM, Tkaczyk C.
  TITLE     Integrated signalling pathways for mast-cell activation.
  JOURNAL   Nat Rev Immunol 6:218-30 (2006)
            DOI:10.1038/nri1782
REFERENCE   PMID:11079101
  AUTHORS   Nadler MJ, Matthews SA, Turner H, Kinet JP.
  TITLE     Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: coupling form to function.
  JOURNAL   Adv Immunol 76:325-55 (2000)
            DOI:10.1016/S0065-2776(01)76022-1
REFERENCE   PMID:11449275
  AUTHORS   Gu H, Saito K, Klaman LD, Shen J, Fleming T, Wang Y, Pratt JC, Lin G, Lim B, Kinet JP, Neel BG.
  TITLE     Essential role for Gab2 in the allergic response.
  JOURNAL   Nature 412:186-90 (2001)
            DOI:10.1038/35084076
REFERENCE   PMID:12145654
  AUTHORS   Nadler MJ, Kinet JP.
  TITLE     Uncovering new complexities in mast cell signaling.
  JOURNAL   Nat Immunol 3:707-8 (2002)
            DOI:10.1038/ni0802-707
REL_PATHWAY mmu00590  Arachidonic acid metabolism
            mmu04010  MAPK signaling pathway
            mmu04070  Phosphatidylinositol signaling system
KO_PATHWAY  ko04664
///
